Velpatasvir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Velpatasvir
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Velpatasvir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 3 EU WC, 1 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

13 API Suppliers
3 EU WC
1 KDMF
3 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 5 FDA Orange Book, 1 Europe, 2 Canada, 1 South Africa, 3 Listed Dossiers

12 FDF Dossiers
5 FDA Orange Book
1 Europe
2 Canada
1 South Africa
3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 6 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
2 Boai NKY Pharmaceuticals Ltd
4 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Actylis
1 Aeon Procare
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
3 BASF
5 Corel Pharma Chem
5 DFE Pharma
6 Gangwal Chemicals
1 Huzhou Sunflower Pharmaceutical
2 Ideal Cures
1 Ingredion Pharma Solutions
13 Kerry
2 Keval Exports
10 Microlex e.U
2 Nitika Pharmaceutical Specialities
2 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders, 20 Coating Systems & Additives, 17 Direct Compression, 15 Granulation, 14 Disintegrants & Superdisintegrants, 12 Lubricants & Glidants, 10 Controlled & Modified Release, 8 Thickeners and Stabilizers, 8 Co-Processed Excipients, 8 Film Formers & Plasticizers, 4 Taste Masking, 3 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Parenteral, 2 Topical, 2 Rheology Modifiers, 2 Solubilizers, 1 Emulsifying Agents, 1 API Stability Enhancers

35 Fillers, Diluents & Binders
20 Coating Systems & Additives
17 Direct Compression
15 Granulation
14 Disintegrants & Superdisintegrants
12 Lubricants & Glidants
10 Controlled & Modified Release
8 Thickeners and Stabilizers
8 Co-Processed Excipients
8 Film Formers & Plasticizers
4 Taste Masking
3 Coloring Agents
3 Chewable & Orodispersible Aids
3 Parenteral
2 Topical
2 Rheology Modifiers
2 Solubilizers
1 Emulsifying Agents
1 API Stability Enhancers

DIGITAL CONTENT

7 News #PharmaBuzz

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 21 Annual Reports

3 US Medicaid Prescriptions
1 Regulatory FDF Prices
21 Annual Reports

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

163 US Patents, 11 US Exclusivities, 4 Health Canada Patents

163 US Patents
11 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 3,758 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gilead Sciences Canada Inc.

filter Patent Reset all filters

4 All

01 12682230

02 12794669

03 12815082

04 12877005

filter Product Reset all filters

4 All

01 4SOFOSBUVIR | VELPATASVIR | VOXILAPREVIR

filter Dosage Reset all filters

4 All

01 4TABLET

filter Exp Date Reset all filters

4 All

01 12028-03-26

02 12031-03-31

03 12032-11-16

04 12033-07-02

Product Main Page

01

Gilead Sciences Canada Inc.

Sofosbuvir, Velpatasvir, Voxilaprevir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-26

Date Granted : 2014-04-22

Sofosbuvir, Velpatasvir, Voxilaprevir

Brand Name : VOSEVI

Patent Number : 2682230

Filing Date : 2008-03-26

Strength per Unit : 400 mg / 100 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-26

Date Granted : 2014-04-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gilead Sciences Canada Inc.

Sofosbuvir, Velpatasvir, Voxilaprevir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-31

Date Granted : 2016-10-11

Sofosbuvir, Velpatasvir, Voxilaprevir

Brand Name : VOSEVI

Patent Number : 2794669

Filing Date : 2011-03-31

Strength per Unit : 400 mg / 100 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-31

Date Granted : 2016-10-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gilead Sciences Canada Inc.

Sofosbuvir, Velpatasvir, Voxilaprevir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-16

Date Granted : 2015-07-07

Sofosbuvir, Velpatasvir, Voxilaprevir

Brand Name : VOSEVI

Patent Number : 2815082

Filing Date : 2012-11-16

Strength per Unit : 400 mg / 100 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-16

Date Granted : 2015-07-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gilead Sciences Canada Inc.

Sofosbuvir, Velpatasvir, Voxilaprevir

Peptide Process CMC

Not Confirmed

Gilead Sciences Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-02

Date Granted : 2016-12-13

Sofosbuvir, Velpatasvir, Voxilaprevir

Brand Name : VOSEVI

Patent Number : 2877005

Filing Date : 2013-07-02

Strength per Unit : 400 mg / 100 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-07-02

Date Granted : 2016-12-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!